کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
6015362 1579913 2015 4 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Short communicationThe effects of lacosamide on depression and anxiety in patients with epilepsy
ترجمه فارسی عنوان
ارتباط کوتاه ارتباطات لکوسامید در افسردگی و اضطراب در بیماران مبتلا به صرع
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی عصب شناسی
چکیده انگلیسی


- Depression and anxiety are common comorbidities in patients with epilepsy.
- We examined NDDI-E and GAD-7 scores prior to and following lacosamide treatment.
- Following treatment, there were no significant changes in GAD-7 scores.
- Patients with an initial NDDI-E > 15 had significant improvements in NDDI-E scores.
- Our results suggest lacosamide is safe to use in patients with mood disorders.

SummaryDepression and anxiety are common in patients with epilepsy. Moreover, some antiepileptic drugs (AEDs) have mood stabilizing and anxiolytic effects, while others may worsen psychiatric symptoms. The effects of lacosamide, a third generation AED approved for the treatment of focal onset seizures, on depressive and anxiety symptoms are unknown. We evaluated changes in depression and anxiety following the initiation of lacosamide. We compared patients' scores on the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E, n = 91) and Generalized Anxiety Disorder 7-item (GAD-7, n = 20) scales prior to and following lacosamide treatment. Following the initiation of lacosamide, there were no significant changes in NDDI-E scores when all patients were analyzed aggregately (baseline: 12.14 ± 4.64 vs post-treatment: 11.91 ± 4.14, p = 0.51). Similarly, the mean GAD-7 scores at baseline (4.10 ± 4.52) and after treatment (4.75 ± 5.51) did not differ (p = 0.23). In the 25 patients with initial NDDI-E scores of >15, lacosamide was associated with a significant decrease in depressive symptoms (baseline: 17.60 ± 1.63 vs post-treatment: 14.64 ± 2.78, p < 0.001). NDDI-E and GAD-7 scores pre- and post-lacosamide initiation were not significantly affected by a history of mood disorders, concomitant psychiatric medications, or concomitant AEDs with mood-stabilizing effects.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Epilepsy Research - Volume 110, February 2015, Pages 115-118
نویسندگان
, , , , ,